OpenVSafe by OpenVAERS
Search V-safe

9ZQ-20660-51829

3 vaccinations 13 coded responses 25 check-ins 13 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
981 / WA
Registered
2021-03-09
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-09
    Registered in v-safe
  3. 2021-03-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tiredness
    Free text: Fuzzyheadedness- Im having trouble keeping everything together today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling abnormal — Feeling: Good · Fatigue or tiredness
    Free text: Fuzziheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Diarrhea
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-16
    Survey response — day 7, dose 1
    MedDRA: No adverse event — Feeling: Good · Diarrhea
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-29
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-29
    Survey response — day 0, dose 2
    MedDRA: No adverse event — Feeling: Good · Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling abnormal — Feeling: Good · Joint pains
    Free text: Fuzzyheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Chills, Joint pains
    Adult check-in
  16. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-04-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Joint pains, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-05
    Survey response — day 7, dose 2
    MedDRA: Mood swings — Feeling: Fair · Fatigue or tiredness
    Free text: Mood swings
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-26
    Survey response — day 28, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Not new, but the fatigue continues.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-03
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-30
    Dose 3 — Pfizer-BioNTech
  27. 2021-09-27
    Survey response — 6 months, dose 2
    MedDRA: Electrocardiogram QT prolonged, Office visit, Pre-existing disease, Urticaria — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Symptoms: Atherosclerosis, uncontrolled high BP despite taking meds every day, prolonged QT, sleep apnea, urticaria attack on arms, sides, stomach that lasted for three weeks & required 6 ceritizine a day & topical steroid cream for 10 days to get rid of · Healthcare visit (other): In person w doctor
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-09-27
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  29. 2021-09-30
  30. 2022-03-29
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2022-08-30
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-08Pfizer-BioNTech
22021-03-29Pfizer-BioNTech
32021-08-30Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-09

Systemic reaction (other): Fuzzyheadedness- Im having trouble keeping everything together today

2021-03-10

Systemic reaction (other): Fuzziheadedness

2021-03-12

Systemic reaction (other): None

2021-03-13

Systemic reaction (other): None

2021-03-14

Systemic reaction (other): None

Release 5 — day 7, dose 1

2021-03-16

Systemic reaction (other): None

Release 6 — day 0, dose 2

2021-03-29

Systemic reaction (other): None

Release 6 — days 1–6 daily, dose 2

2021-03-31

Systemic reaction (other): Fuzzyheadedness

2021-04-02

Systemic reaction (other): None

2021-04-04

Systemic reaction (other): None

Release 6 — day 7, dose 2

2021-04-05

Systemic reaction (other): Mood swings

Release 8 — day 28, dose 2

2021-04-26

Symptoms: Not new, but the fatigue continues.

Release 9 — 6 months, dose 2

2021-09-27

Symptoms: Atherosclerosis, uncontrolled high BP despite taking meds every day, prolonged QT, sleep apnea, urticaria attack on arms, sides, stomach that lasted for three weeks & required 6 ceritizine a day & topical steroid cream for 10 days to get rid of
Healthcare visit (other): In person w doctor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDElectrocardiogram QT prolonged · · ✓
SDFatigue ✓ ✓ ✓
SDPre-existing disease · · ✓
SDUrticaria · · ✓
SROFeeling abnormal ✓ ✓ ✓
SROMood swings ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release